. (WCRX)
$22.93 - (-)
Market Cap: -
As of 11/14/13 12:00 AM EST. Market closed.
. (WCRX)
$22.93
- (-)
Market Cap: -
As of 11/14/13 12:00 AM EST. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$22.93
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$22.93
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Halstead Michael | Senior V.P., Corp. Development | Jul 01, 2013 | Sale | $19.88 | 366 | 7,276 | 51,840 | Jul 02, 2013, 05:43 PM |
Sullivan Ryan T | VP, General Counsel & Secr. | Jul 01, 2013 | Sale | $19.88 | 169 | 3,360 | 26,460 | Jul 02, 2013, 05:42 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Apr 01, 2013 | Sale | $13.41 | 703 | 9,428 | 144,838 | Apr 01, 2013, 04:39 PM |
CONNAUGHTON JOHN | Director | Mar 04, 2013 | Sale | $13.47 | 10,590,608 | 142,655,493 | 0 | Mar 06, 2013, 05:12 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Mar 01, 2013 | Sale | $13.38 | 1,666 | 22,293 | 181,223 | Mar 04, 2013, 04:04 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Feb 28, 2013 | Sale | $13.46 | 15,869 | 213,655 | 145,541 | Mar 01, 2013, 04:19 PM |
Rodriguez Rama Francisco | Senior V.P., Tech. Operations | Feb 28, 2013 | Sale | $13.46 | 820 | 11,040 | 30,529 | Mar 01, 2013, 04:13 PM |
Gilligan Claire A | Senior V.P., Quality | Feb 28, 2013 | Sale | $13.46 | 2,354 | 31,694 | 77,632 | Mar 01, 2013, 04:13 PM |
Cross Leland H | Senior V.P., Tech. Operations | Feb 28, 2013 | Sale | $13.46 | 1,324 | 17,826 | 204,826 | Mar 01, 2013, 04:12 PM |
Fenton Andrew | Senior V.P., CIO | Feb 28, 2013 | Sale | $13.46 | 1,390 | 18,715 | 108,310 | Mar 01, 2013, 04:11 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Feb 28, 2013 | Sale | $13.46 | 1,728 | 23,265 | 99,689 | Mar 01, 2013, 04:10 PM |
Halstead Michael | Senior V.P., Corp. Development | Feb 28, 2013 | Sale | $13.46 | 1,747 | 23,521 | 52,206 | Mar 01, 2013, 04:10 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Feb 28, 2013 | Sale | $13.46 | 1,728 | 23,265 | 56,546 | Mar 01, 2013, 04:09 PM |
Herendeen Paul | Exec. V.P. and CFO | Feb 28, 2013 | Sale | $13.46 | 4,674 | 62,929 | 132,620 | Mar 01, 2013, 04:08 PM |
Boissonneault Roger M | CEO & President | Feb 28, 2013 | Sale | $13.46 | 18,730 | 252,175 | 2,312,618 | Mar 01, 2013, 04:07 PM |
Fenton Andrew | Senior V.P., CIO | Feb 19, 2013 | Sale | $14.53 | 419 | 6,087 | 109,700 | Feb 21, 2013, 04:12 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Feb 19, 2013 | Sale | $14.53 | 691 | 10,039 | 182,889 | Feb 21, 2013, 04:11 PM |
Gilligan Claire A | Senior V.P., Quality | Feb 19, 2013 | Sale | $14.53 | 1,045 | 15,181 | 79,986 | Feb 21, 2013, 04:11 PM |
Cross Leland H | Senior V.P., Tech. Operations | Feb 19, 2013 | Sale | $14.53 | 553 | 8,034 | 206,150 | Feb 21, 2013, 04:10 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Feb 19, 2013 | Sale | $14.53 | 767 | 11,143 | 101,417 | Feb 21, 2013, 04:09 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Feb 19, 2013 | Sale | $14.53 | 2,562 | 37,220 | 129,673 | Feb 21, 2013, 04:07 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Feb 19, 2013 | Sale | $14.53 | 767 | 11,143 | 58,274 | Feb 21, 2013, 04:06 PM |
Halstead Michael | Senior V.P., Corp. Development | Feb 19, 2013 | Sale | $14.53 | 419 | 6,087 | 53,953 | Feb 21, 2013, 04:05 PM |
Herendeen Paul | Exec. V.P. and CFO | Feb 19, 2013 | Sale | $14.53 | 1,969 | 28,605 | 137,294 | Feb 21, 2013, 04:04 PM |
Boissonneault Roger M | CEO & President | Feb 19, 2013 | Sale | $14.53 | 7,928 | 115,176 | 2,331,348 | Feb 21, 2013, 04:03 PM |
Fenton Andrew | Senior V.P., CIO | Feb 01, 2013 | Sale | $14.18 | 996 | 14,121 | 94,649 | Feb 04, 2013, 04:12 PM |
Cross Leland H | Senior V.P., Tech. Operations | Feb 01, 2013 | Sale | $14.18 | 808 | 11,456 | 191,233 | Feb 04, 2013, 04:11 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Feb 01, 2013 | Sale | $14.18 | 1,010 | 14,320 | 168,110 | Feb 04, 2013, 04:11 PM |
Halstead Michael | Senior V.P., Corp. Development | Feb 01, 2013 | Sale | $14.18 | 998 | 14,150 | 38,902 | Feb 04, 2013, 04:10 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Feb 01, 2013 | Sale | $14.18 | 1,010 | 14,320 | 86,714 | Feb 04, 2013, 04:10 PM |
Gilligan Claire A | Senior V.P., Quality | Feb 01, 2013 | Sale | $14.18 | 1,377 | 19,523 | 65,561 | Feb 04, 2013, 04:09 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Feb 01, 2013 | Sale | $14.18 | 998 | 14,150 | 43,571 | Feb 04, 2013, 04:08 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Feb 01, 2013 | Sale | $14.18 | 13,790 | 195,517 | 132,235 | Feb 04, 2013, 04:07 PM |
Herendeen Paul | Exec. V.P. and CFO | Feb 01, 2013 | Sale | $14.18 | 2,840 | 40,266 | 101,543 | Feb 04, 2013, 04:03 PM |
Boissonneault Roger M | CEO & President | Feb 01, 2013 | Sale | $14.18 | 9,125 | 129,376 | 2,222,156 | Feb 04, 2013, 04:02 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 30, 2013 | Sale | $13.38 | 465 | 6,224 | 192,041 | Jan 31, 2013, 04:48 PM |
Gilligan Claire A | Senior V.P., Quality | Jan 30, 2013 | Sale | $13.38 | 489 | 6,545 | 66,938 | Jan 31, 2013, 04:48 PM |
Fenton Andrew | Senior V.P., CIO | Jan 30, 2013 | Sale | $13.38 | 351 | 4,698 | 95,645 | Jan 31, 2013, 04:47 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 30, 2013 | Sale | $13.38 | 586 | 7,843 | 169,120 | Jan 31, 2013, 04:47 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 30, 2013 | Sale | $13.38 | 591 | 7,910 | 87,724 | Jan 31, 2013, 04:46 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Jan 30, 2013 | Sale | $13.38 | 282 | 3,774 | 44,569 | Jan 31, 2013, 04:45 PM |
Halstead Michael | Senior V.P., Corp. Development | Jan 30, 2013 | Sale | $13.38 | 320 | 4,283 | 39,900 | Jan 31, 2013, 04:45 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Jan 30, 2013 | Sale | $14.28 | 2,215 | 31,621 | 146,333 | Jan 31, 2013, 04:44 PM |
Herendeen Paul | Exec. V.P. and CFO | Jan 30, 2013 | Sale | $13.38 | 2,208 | 29,552 | 104,383 | Jan 31, 2013, 04:43 PM |
Boissonneault Roger M | CEO & President | Jan 30, 2013 | Sale | $13.38 | 8,470 | 113,363 | 2,231,281 | Jan 31, 2013, 04:43 PM |
Fenton Andrew | Senior V.P., CIO | Jan 22, 2013 | Sale | $13.50 | 621 | 8,383 | 95,996 | Jan 23, 2013, 04:13 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 22, 2013 | Sale | $13.50 | 1,166 | 15,741 | 169,706 | Jan 23, 2013, 04:12 PM |
Gilligan Claire A | Senior V.P., Quality | Jan 22, 2013 | Sale | $13.50 | 949 | 12,811 | 67,427 | Jan 23, 2013, 04:11 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 22, 2013 | Sale | $13.50 | 1,222 | 16,497 | 88,315 | Jan 23, 2013, 04:10 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 22, 2013 | Sale | $13.50 | 839 | 11,326 | 192,506 | Jan 23, 2013, 04:10 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Jan 22, 2013 | Sale | $13.50 | 488 | 6,588 | 44,851 | Jan 23, 2013, 04:09 PM |
Halstead Michael | Senior V.P., Corp. Development | Jan 22, 2013 | Sale | $13.50 | 488 | 6,588 | 40,220 | Jan 23, 2013, 04:08 PM |
Herendeen Paul | Exec. V.P. and CFO | Jan 22, 2013 | Sale | $13.50 | 4,305 | 58,117 | 106,591 | Jan 23, 2013, 04:07 PM |
Boissonneault Roger M | CEO & President | Jan 22, 2013 | Sale | $13.50 | 13,924 | 187,973 | 2,239,751 | Jan 23, 2013, 04:06 PM |
Murray Stephen P | Director | Nov 28, 2012 | Sale | $11.41 | 6,491,618 | 74,069,360 | 0 | Nov 30, 2012, 03:11 PM |
Murray Stephen P | Director | Nov 20, 2012 | Sale | $11.66 | 5,000,000 | 58,299,999 | 6,491,618 | Nov 20, 2012, 10:47 AM |
Gilligan Claire A | Senior V.P., Quality | Oct 01, 2012 | Sale | $13.55 | 264 | 3,577 | 68,376 | Oct 01, 2012, 04:41 PM |
Halstead Michael | Senior V.P., Corp. Development | Oct 01, 2012 | Sale | $13.55 | 77 | 1,043 | 40,708 | Oct 01, 2012, 04:40 PM |
BAIN CAPITAL INVESTORS LLC | 10% Owner | Sep 11, 2012 | Sale | $13.10 | 12,890,449 | 168,864,887 | 11,491,622 | Sep 13, 2012, 05:29 PM |
CONNAUGHTON JOHN | Director | Sep 11, 2012 | Sale | $13.10 | 12,890,449 | 168,864,887 | 11,491,622 | Sep 13, 2012, 05:29 PM |
THL WC (Dutch) B.V. | 10% Owner | Sep 11, 2012 | Sale | $13.10 | 14,000,000 | 183,400,005 | 11,491,622 | Sep 13, 2012, 04:54 PM |
ABBRECHT TODD M | Director | Sep 11, 2012 | Sale | $13.10 | 14,000,000 | 183,400,005 | 11,491,622 | Sep 13, 2012, 04:53 PM |
Hara Izumi | Senior V.P. | Sep 11, 2012 | Sale | $13.10 | 126,993 | 1,663,608 | 73,885 | Sep 12, 2012, 04:11 PM |
Herendeen Paul | Exec. V.P. and CFO | Sep 11, 2012 | Sale | $13.10 | 309,240 | 4,051,044 | 110,896 | Sep 12, 2012, 04:10 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Sep 11, 2012 | Sale | $13.10 | 147,639 | 1,934,071 | 89,537 | Sep 12, 2012, 04:08 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Sep 11, 2012 | Sale | $13.10 | 23,500 | 307,850 | 170,872 | Sep 12, 2012, 04:07 PM |
Murray Stephen P | Director | Sep 11, 2012 | Sale | $13.10 | 14,000,000 | 183,400,005 | 11,491,618 | Sep 12, 2012, 10:26 AM |
JPMP MASTER FUND MANAGER L P | 10% Owner | Sep 11, 2012 | Sale | $13.10 | 28,762,425 | 376,787,778 | 11,491,618 | Sep 11, 2012, 03:45 PM |
JP MORGAN PARTNERS BHCA LP | 10% Owner | Sep 11, 2012 | Sale | $13.10 | 28,762,425 | 376,787,778 | 11,491,618 | Sep 11, 2012, 03:03 PM |
Halstead Michael | Senior V.P., Corp. Development | Jul 02, 2012 | Sale | $17.96 | 355 | 6,376 | 40,785 | Jul 02, 2012, 04:30 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Apr 02, 2012 | Sale | $16.95 | 703 | 11,916 | 148,240 | Apr 03, 2012, 04:03 PM |
Cross Leland H | Senior V.P., Tech. Operations | Mar 01, 2012 | Sale | $17.00 | 558 | 9,486 | 193,345 | Mar 02, 2012, 04:25 PM |
Fenton Andrew | Senior V.P., CIO | Mar 01, 2012 | Sale | $17.00 | 386 | 6,562 | 96,617 | Mar 02, 2012, 04:23 PM |
Gilligan Claire A | Senior V.P., Quality | Mar 01, 2012 | Sale | $17.00 | 973 | 16,540 | 68,640 | Mar 02, 2012, 04:20 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Mar 01, 2012 | Sale | $17.00 | 710 | 12,069 | 200,878 | Mar 02, 2012, 04:18 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Mar 01, 2012 | Sale | $17.00 | 710 | 12,069 | 237,176 | Mar 02, 2012, 04:16 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Mar 01, 2012 | Sale | $17.00 | 710 | 12,069 | 45,339 | Mar 02, 2012, 04:13 PM |
Halstead Michael | Senior V.P., Corp. Development | Mar 01, 2012 | Sale | $17.00 | 725 | 12,324 | 41,140 | Mar 02, 2012, 04:12 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Mar 01, 2012 | Sale | $17.00 | 2,485 | 42,243 | 148,943 | Mar 02, 2012, 04:08 PM |
Herendeen Paul | Exec. V.P. and CFO | Mar 01, 2012 | Sale | $17.00 | 1,827 | 31,058 | 420,136 | Mar 02, 2012, 03:59 PM |
Boissonneault Roger M | CEO & President | Mar 01, 2012 | Sale | $17.00 | 5,320 | 90,436 | 2,253,675 | Mar 02, 2012, 03:58 PM |
Fenton Andrew | Senior V.P., CIO | Feb 21, 2012 | Sale | $16.82 | 409 | 6,880 | 97,003 | Feb 23, 2012, 04:36 PM |
Gilligan Claire A | Senior V.P., Quality | Feb 21, 2012 | Sale | $16.82 | 1,030 | 17,327 | 69,613 | Feb 23, 2012, 04:34 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Feb 21, 2012 | Sale | $16.82 | 752 | 12,651 | 201,588 | Feb 23, 2012, 04:28 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Feb 21, 2012 | Sale | $16.82 | 752 | 12,651 | 237,886 | Feb 23, 2012, 04:24 PM |
Cross Leland H | Senior V.P., Tech. Operations | Feb 21, 2012 | Sale | $16.82 | 590 | 9,925 | 193,903 | Feb 23, 2012, 04:22 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Feb 21, 2012 | Sale | $16.82 | 752 | 12,651 | 46,049 | Feb 23, 2012, 04:20 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Feb 21, 2012 | Sale | $16.82 | 677 | 11,389 | 194,372 | Feb 23, 2012, 04:17 PM |
Halstead Michael | Senior V.P., Corp. Development | Feb 21, 2012 | Sale | $16.82 | 409 | 6,880 | 41,865 | Feb 23, 2012, 04:14 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Feb 21, 2012 | Sale | $16.82 | 2,561 | 43,082 | 146,458 | Feb 23, 2012, 04:08 PM |
Herendeen Paul | Exec. V.P. and CFO | Feb 21, 2012 | Sale | $16.82 | 1,933 | 32,518 | 421,963 | Feb 23, 2012, 04:08 PM |
Boissonneault Roger M | CEO & President | Feb 21, 2012 | Sale | $16.82 | 5,628 | 94,677 | 2,258,995 | Feb 23, 2012, 04:07 PM |
Fenton Andrew | Senior V.P., CIO | Jan 30, 2012 | Sale | $16.45 | 351 | 5,775 | 76,622 | Jan 31, 2012, 05:41 PM |
Gilligan Claire A | Senior V.P., Quality | Jan 30, 2012 | Sale | $16.45 | 480 | 7,897 | 49,853 | Jan 31, 2012, 05:39 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Jan 30, 2012 | Sale | $16.45 | 635 | 10,447 | 181,550 | Jan 31, 2012, 05:36 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 30, 2012 | Sale | $16.45 | 579 | 9,526 | 217,848 | Jan 31, 2012, 05:33 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 30, 2012 | Sale | $16.45 | 504 | 8,292 | 173,703 | Jan 31, 2012, 05:31 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Jan 30, 2012 | Sale | $16.45 | 281 | 4,623 | 26,011 | Jan 31, 2012, 05:28 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 30, 2012 | Sale | $16.45 | 579 | 9,526 | 174,259 | Jan 31, 2012, 05:25 PM |
Halstead Michael | Senior V.P., Corp. Development | Jan 30, 2012 | Sale | $16.45 | 320 | 5,265 | 21,484 | Jan 31, 2012, 05:23 PM |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | Jan 30, 2012 | Sale | $16.45 | 2,215 | 36,441 | 38,699 | Jan 31, 2012, 05:21 PM |
Herendeen Paul | Exec. V.P. and CFO | Jan 30, 2012 | Sale | $16.45 | 2,187 | 35,980 | 365,376 | Jan 31, 2012, 05:04 PM |
Boissonneault Roger M | CEO & President | Jan 30, 2012 | Sale | $16.45 | 8,317 | 136,829 | 2,095,663 | Jan 31, 2012, 05:01 PM |
Fenton Andrew | Senior V.P., CIO | Jan 23, 2012 | Sale | $17.32 | 621 | 10,755 | 76,973 | Jan 24, 2012, 05:00 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Jan 23, 2012 | Sale | $17.32 | 1,169 | 20,246 | 182,185 | Jan 24, 2012, 04:57 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 23, 2012 | Sale | $17.32 | 1,225 | 21,216 | 218,427 | Jan 24, 2012, 04:54 PM |
Gilligan Claire A | Senior V.P., Quality | Jan 23, 2012 | Sale | $17.32 | 933 | 16,159 | 50,333 | Jan 24, 2012, 04:51 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Jan 23, 2012 | Sale | $17.32 | 487 | 8,435 | 26,292 | Jan 24, 2012, 04:49 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 23, 2012 | Sale | $17.32 | 1,169 | 20,246 | 174,838 | Jan 24, 2012, 04:47 PM |
Halstead Michael | Senior V.P., Corp. Development | Jan 23, 2012 | Sale | $17.32 | 487 | 8,435 | 21,804 | Jan 24, 2012, 04:46 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 23, 2012 | Sale | $17.32 | 921 | 15,951 | 174,207 | Jan 24, 2012, 04:44 PM |
Herendeen Paul | Exec. V.P. and CFO | Jan 23, 2012 | Sale | $17.32 | 4,149 | 71,859 | 367,563 | Jan 24, 2012, 04:41 PM |
Boissonneault Roger M | CEO & President | Jan 23, 2012 | Sale | $17.32 | 13,652 | 236,446 | 2,103,980 | Jan 24, 2012, 04:36 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 11, 2012 | Sale | $16.66 | 1,146 | 19,093 | 219,652 | Jan 12, 2012, 04:22 PM |
Fuhrmann Rochelle | Senior V.P., Finance | Jan 11, 2012 | Sale | $16.66 | 411 | 6,847 | 26,779 | Jan 12, 2012, 04:18 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 11, 2012 | Sale | $16.66 | 1,042 | 17,360 | 176,007 | Jan 12, 2012, 04:16 PM |
Halstead Michael | Senior V.P., Corp. Development | Jan 11, 2012 | Sale | $16.66 | 452 | 7,531 | 22,291 | Jan 12, 2012, 04:14 PM |
Fenton Andrew | Senior V.P., CIO | Jan 11, 2012 | Sale | $16.66 | 558 | 9,297 | 77,594 | Jan 12, 2012, 04:12 PM |
Gilligan Claire A | Senior V.P., Quality | Jan 11, 2012 | Sale | $16.66 | 839 | 13,978 | 51,266 | Jan 12, 2012, 04:09 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 11, 2012 | Sale | $16.66 | 908 | 15,128 | 175,128 | Jan 12, 2012, 04:07 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Jan 11, 2012 | Sale | $16.66 | 1,095 | 18,243 | 183,354 | Jan 12, 2012, 04:03 PM |
Fawzi Mahdi B | President, Research & Develop. | Oct 21, 2011 | Sale | $16.80 | 2,418 | 40,623 | 57,755 | Oct 24, 2011, 04:23 PM |
Gilligan Claire A | Senior V.P., Quality | Oct 03, 2011 | Sale | $14.03 | 270 | 3,788 | 52,105 | Oct 03, 2011, 04:06 PM |
Halstead Michael | Senior V.P., Corp. Development | Oct 03, 2011 | Sale | $14.03 | 78 | 1,094 | 22,743 | Oct 03, 2011, 04:06 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jun 10, 2011 | Sale | $22.29 | 79,563 | 1,773,746 | 176,036 | Jun 13, 2011, 04:39 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jun 09, 2011 | Sale | $22.41 | 100,000 | 2,241,010 | 255,599 | Jun 13, 2011, 04:39 PM |
van Zoonen Marinus Johannes | Pres., Europe/Int'l&Glob. Mkt. | Apr 01, 2011 | Sale | $23.30 | 703 | 16,380 | 40,914 | Apr 04, 2011, 04:13 PM |
CONNAUGHTON JOHN | Director | Mar 30, 2011 | Sale | $22.44 | 466,196 | 10,459,713 | 25,491,622 | Apr 01, 2011, 05:23 PM |
BAIN CAPITAL INVESTORS LLC | 10% Owner | Mar 30, 2011 | Sale | $22.44 | 466,196 | 10,459,713 | 25,491,622 | Apr 01, 2011, 05:23 PM |
THL WC (Dutch) B.V. | 10% Owner | Mar 30, 2011 | Sale | $22.44 | 466,194 | 10,461,394 | 25,491,622 | Apr 01, 2011, 12:17 PM |
BAIN CAPITAL INVESTORS LLC | 10% Owner | Mar 30, 2011 | Sale | $22.44 | 446,196 | 10,010,987 | 25,511,622 | Apr 01, 2011, 12:02 PM |
CONNAUGHTON JOHN | Director | Mar 30, 2011 | Sale | $22.44 | 446,196 | 10,010,987 | 25,511,622 | Apr 01, 2011, 12:01 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Mar 30, 2011 | Sale | $23.25 | 3,713 | 86,327 | 184,449 | Mar 31, 2011, 04:20 PM |
Gilligan Claire A | Senior V.P. Global Quality | Mar 30, 2011 | Sale | $23.25 | 1,031 | 23,971 | 52,375 | Mar 31, 2011, 04:20 PM |
Gilligan Claire A | Senior V.P. Global Quality | Mar 30, 2011 | Sale | $23.25 | 512 | 11,904 | 28,049 | Mar 31, 2011, 04:20 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Mar 30, 2011 | Sale | $23.25 | 3,546 | 82,445 | 177,049 | Mar 31, 2011, 04:19 PM |
Herendeen Paul | Exec. V.P. and CFO | Mar 30, 2011 | Sale | $23.25 | 15,406 | 358,190 | 371,712 | Mar 31, 2011, 04:19 PM |
Reichel Carl W | President, Pharmaceuticals | Mar 30, 2011 | Sale | $23.25 | 18,020 | 418,965 | 371,594 | Mar 31, 2011, 04:18 PM |
Bruno Anthony D | Exec. V.P., Corp. Development | Mar 30, 2011 | Sale | $23.25 | 16,848 | 391,716 | 308,123 | Mar 31, 2011, 04:17 PM |
JPMP MASTER FUND MANAGER L P | 10% Owner | Mar 30, 2011 | Sale | $22.44 | 932,389 | 20,919,360 | 25,491,618 | Mar 30, 2011, 05:35 PM |
JP MORGAN PARTNERS BHCA LP | 10% Owner | Mar 30, 2011 | Sale | $22.44 | 932,389 | 20,919,360 | 25,491,618 | Mar 30, 2011, 05:34 PM |
Murray Stephen P | Director | Mar 30, 2011 | Sale | $22.44 | 466,194 | 10,459,669 | 25,491,618 | Mar 30, 2011, 05:31 PM |
CONNAUGHTON JOHN | Director | Mar 16, 2011 | Sale | $22.44 | 6,919,748 | 155,253,544 | 25,957,818 | Mar 18, 2011, 05:51 PM |
BAIN CAPITAL INVESTORS LLC | 10% Owner | Mar 16, 2011 | Sale | $22.44 | 6,919,748 | 155,253,544 | 25,957,818 | Mar 18, 2011, 05:28 PM |
JPMP MASTER FUND MANAGER L P | 10% Owner | Mar 16, 2011 | Sale | $22.44 | 15,722,194 | 352,747,866 | 25,957,812 | Mar 18, 2011, 03:42 PM |
JP MORGAN PARTNERS BHCA LP | 10% Owner | Mar 16, 2011 | Sale | $22.44 | 15,722,194 | 352,747,866 | 25,957,812 | Mar 18, 2011, 03:40 PM |
THL WC (Dutch) B.V. | 10% Owner | Mar 16, 2011 | Sale | $23.25 | 7,861,448 | 182,778,666 | 25,957,816 | Mar 18, 2011, 02:25 PM |
MURRAY STEPHEN | Director | Mar 16, 2011 | Sale | $22.44 | 7,861,447 | 176,381,786 | 25,957,812 | Mar 18, 2011, 02:05 PM |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | Mar 16, 2011 | Sale | $23.25 | 63,531 | 1,477,096 | 188,162 | Mar 17, 2011, 04:02 PM |
Gilligan Claire A | Senior V.P. Global Quality | Mar 16, 2011 | Sale | $23.25 | 8,774 | 203,996 | 28,561 | Mar 17, 2011, 04:02 PM |
Gilligan Claire A | Senior V.P. Global Quality | Mar 16, 2011 | Sale | $23.25 | 17,637 | 410,060 | 53,406 | Mar 17, 2011, 04:02 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Mar 16, 2011 | Sale | $23.25 | 60,668 | 1,410,531 | 180,595 | Mar 17, 2011, 04:02 PM |
Bruno Anthony D | Exec. V.P., Corp. Development | Mar 16, 2011 | Sale | $23.25 | 400,000 | 9,300,000 | 324,971 | Mar 17, 2011, 04:02 PM |
Herendeen Paul | Exec. V.P. and CFO | Mar 16, 2011 | Sale | $23.25 | 400,000 | 9,300,000 | 387,118 | Mar 17, 2011, 04:01 PM |
Reichel Carl W | President, Pharmaceuticals | Mar 16, 2011 | Sale | $23.25 | 400,000 | 9,300,000 | 389,614 | Mar 17, 2011, 04:01 PM |
Fuhrmann Rochelle | Senior V.P., Global Finance | Jan 31, 2011 | Sale | $23.35 | 278 | 6,491 | 11,510 | Feb 01, 2011, 04:18 PM |
Gilligan Claire A | Senior V.P. Global Quality | Jan 31, 2011 | Sale | $23.35 | 474 | 11,068 | 55,363 | Feb 01, 2011, 04:17 PM |
van Zoonen Marinus Johannes | Pres., Europe/Int'l&Glob. Mkt. | Jan 31, 2011 | Sale | $23.35 | 2,215 | 51,719 | 21,127 | Feb 01, 2011, 04:17 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 31, 2011 | Sale | $23.35 | 572 | 13,356 | 227,153 | Feb 01, 2011, 04:16 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 31, 2011 | Sale | $23.35 | 572 | 13,356 | 341,489 | Feb 01, 2011, 04:15 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 31, 2011 | Sale | $23.35 | 572 | 13,356 | 205,118 | Feb 01, 2011, 04:15 PM |
Herendeen Paul | Exec. V.P. and CFO | Jan 31, 2011 | Sale | $23.35 | 2,152 | 50,248 | 746,748 | Feb 01, 2011, 04:14 PM |
Bruno Anthony D | Exec. V.P., Corp. Development | Jan 31, 2011 | Sale | $23.35 | 2,152 | 50,248 | 684,601 | Feb 01, 2011, 04:14 PM |
Reichel Carl W | President, Pharmaceuticals | Jan 31, 2011 | Sale | $23.35 | 2,152 | 50,248 | 749,244 | Feb 01, 2011, 04:13 PM |
Boissonneault Roger M | CEO & President | Jan 31, 2011 | Sale | $23.35 | 8,228 | 192,120 | 2,000,062 | Feb 01, 2011, 04:12 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 21, 2011 | Sale | $23.62 | 1,054 | 24,898 | 342,061 | Jan 24, 2011, 06:03 PM |
Fuhrmann Rochelle | Senior V.P., Global Finance | Jan 21, 2011 | Sale | $23.62 | 485 | 11,457 | 11,788 | Jan 24, 2011, 06:01 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 21, 2011 | Sale | $23.62 | 1,164 | 27,496 | 227,725 | Jan 24, 2011, 06:01 PM |
Gilligan Claire A | Senior V.P. Global Quality | Jan 21, 2011 | Sale | $23.62 | 929 | 21,945 | 55,837 | Jan 24, 2011, 06:00 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 21, 2011 | Sale | $23.62 | 1,219 | 28,795 | 205,690 | Jan 24, 2011, 05:58 PM |
Reichel Carl W | President, Pharmaceuticals | Jan 21, 2011 | Sale | $23.62 | 4,096 | 96,757 | 751,396 | Jan 24, 2011, 05:56 PM |
Herendeen Paul | Exec. V.P. and CFO | Jan 21, 2011 | Sale | $23.62 | 4,096 | 96,757 | 748,900 | Jan 24, 2011, 05:55 PM |
Bruno Anthony D | Exec. V.P., Corp. Development | Jan 21, 2011 | Sale | $23.62 | 4,097 | 96,780 | 686,753 | Jan 24, 2011, 05:54 PM |
Boissonneault Roger M | CEO & President | Jan 21, 2011 | Sale | $23.62 | 13,580 | 320,789 | 2,008,290 | Jan 24, 2011, 05:48 PM |
Cross Leland H | Senior V.P., Tech. Operations | Jan 11, 2011 | Sale | $23.85 | 1,030 | 24,566 | 343,115 | Jan 11, 2011, 06:46 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Jan 11, 2011 | Sale | $23.85 | 1,133 | 27,022 | 206,909 | Jan 11, 2011, 06:46 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Jan 11, 2011 | Sale | $23.85 | 1,030 | 24,566 | 228,889 | Jan 11, 2011, 06:45 PM |
Gilligan Claire A | Senior V.P. Global Quality | Jan 11, 2011 | Sale | $23.85 | 829 | 19,772 | 56,766 | Jan 11, 2011, 06:45 PM |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | Sep 27, 2010 | Sale | $22.68 | 651,028 | 14,765,315 | 0 | Nov 01, 2010, 03:38 PM |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | Sep 24, 2010 | Sale | $22.78 | 1,649,645 | 37,578,914 | 651,028 | Nov 01, 2010, 03:38 PM |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | Sep 23, 2010 | Sale | $22.85 | 393,237 | 8,985,466 | 2,300,673 | Nov 01, 2010, 03:38 PM |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | Sep 22, 2010 | Sale | $22.92 | 481,240 | 11,030,021 | 2,693,910 | Nov 01, 2010, 03:38 PM |
Fawzi Mahdi B | President, Research & Develop. | Oct 21, 2010 | Sale | $24.20 | 2,467 | 59,701 | 23,833 | Oct 21, 2010, 05:41 PM |
CREDIT SUISSE AG/ | 10% Owner | Sep 30, 2010 | Sale | $21.48 | 15,000,000 | 322,199,993 | 10,225,584 | Oct 04, 2010, 11:00 AM |
CREDIT SUISSE AG/ | 10% Owner | Sep 29, 2010 | Sale | $22.50 | 322,797 | 7,263,190 | 25,225,584 | Oct 01, 2010, 02:31 PM |
CREDIT SUISSE AG/ | 10% Owner | Sep 28, 2010 | Sale | $22.53 | 575,000 | 12,955,440 | 25,548,651 | Sep 30, 2010, 03:45 PM |
Gilligan Claire A | Senior V.P. Global Quality | Sep 22, 2010 | Sale | $23.05 | 956 | 22,034 | 55,555 | Sep 22, 2010, 04:57 PM |
Cross Leland H | Senior V.P., Tech. Operations | Sep 22, 2010 | Sale | $23.05 | 1,171 | 26,990 | 344,145 | Sep 22, 2010, 04:56 PM |
Howard Alvin D | Sr. V.P., Regulatory Affairs | Sep 22, 2010 | Sale | $23.05 | 1,422 | 32,775 | 208,042 | Sep 22, 2010, 04:56 PM |
Ellman Herman | Senior V.P., Clinical Devel. | Sep 22, 2010 | Sale | $23.05 | 1,171 | 26,990 | 229,919 | Sep 22, 2010, 04:55 PM |
CREDIT SUISSE AG/ | 10% Owner | Sep 14, 2010 | Sale | $22.01 | 124,717 | 2,745,383 | 26,123,651 | Sep 16, 2010, 03:24 PM |
CREDIT SUISSE AG/ | 10% Owner | Sep 13, 2010 | Sale | $22.05 | 38,712 | 853,673 | 26,248,368 | Sep 14, 2010, 04:31 PM |
CREDIT SUISSE AG/ | 10% Owner | Sep 10, 2010 | Sale | $22.03 | 109,800 | 2,419,103 | 26,287,080 | Sep 14, 2010, 04:31 PM |
BLOEM JAMES H | Director | Aug 13, 2010 | Option Exercise | $16.23 | 19,176 | 311,308 | 24,176 | Aug 17, 2010, 11:50 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Halstead Michael | Senior V.P., Corp. Development | 07/01/2013 | 7,276 |
Sullivan Ryan T | VP, General Counsel & Secr. | 07/01/2013 | 3,360 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 04/01/2013 | 9,428 |
CONNAUGHTON JOHN | Director | 03/04/2013 | 142,655,493 |
Ellman Herman | Senior V.P., Clinical Devel. | 03/01/2013 | 22,293 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 02/28/2013 | 213,655 |
Rodriguez Rama Francisco | Senior V.P., Tech. Operations | 02/28/2013 | 11,040 |
Gilligan Claire A | Senior V.P., Quality | 02/28/2013 | 31,694 |
Cross Leland H | Senior V.P., Tech. Operations | 02/28/2013 | 17,826 |
Fenton Andrew | Senior V.P., CIO | 02/28/2013 | 18,715 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 02/28/2013 | 23,265 |
Halstead Michael | Senior V.P., Corp. Development | 02/28/2013 | 23,521 |
Fuhrmann Rochelle | Senior V.P., Finance | 02/28/2013 | 23,265 |
Herendeen Paul | Exec. V.P. and CFO | 02/28/2013 | 62,929 |
Boissonneault Roger M | CEO & President | 02/28/2013 | 252,175 |
Fenton Andrew | Senior V.P., CIO | 02/19/2013 | 6,087 |
Ellman Herman | Senior V.P., Clinical Devel. | 02/19/2013 | 10,039 |
Gilligan Claire A | Senior V.P., Quality | 02/19/2013 | 15,181 |
Cross Leland H | Senior V.P., Tech. Operations | 02/19/2013 | 8,034 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 02/19/2013 | 11,143 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 02/19/2013 | 37,220 |
Fuhrmann Rochelle | Senior V.P., Finance | 02/19/2013 | 11,143 |
Halstead Michael | Senior V.P., Corp. Development | 02/19/2013 | 6,087 |
Herendeen Paul | Exec. V.P. and CFO | 02/19/2013 | 28,605 |
Boissonneault Roger M | CEO & President | 02/19/2013 | 115,176 |
Fenton Andrew | Senior V.P., CIO | 02/01/2013 | 14,121 |
Cross Leland H | Senior V.P., Tech. Operations | 02/01/2013 | 11,456 |
Ellman Herman | Senior V.P., Clinical Devel. | 02/01/2013 | 14,320 |
Halstead Michael | Senior V.P., Corp. Development | 02/01/2013 | 14,150 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 02/01/2013 | 14,320 |
Gilligan Claire A | Senior V.P., Quality | 02/01/2013 | 19,523 |
Fuhrmann Rochelle | Senior V.P., Finance | 02/01/2013 | 14,150 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 02/01/2013 | 195,517 |
Herendeen Paul | Exec. V.P. and CFO | 02/01/2013 | 40,266 |
Boissonneault Roger M | CEO & President | 02/01/2013 | 129,376 |
Cross Leland H | Senior V.P., Tech. Operations | 01/30/2013 | 6,224 |
Gilligan Claire A | Senior V.P., Quality | 01/30/2013 | 6,545 |
Fenton Andrew | Senior V.P., CIO | 01/30/2013 | 4,698 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/30/2013 | 7,843 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/30/2013 | 7,910 |
Fuhrmann Rochelle | Senior V.P., Finance | 01/30/2013 | 3,774 |
Halstead Michael | Senior V.P., Corp. Development | 01/30/2013 | 4,283 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 01/30/2013 | 31,621 |
Herendeen Paul | Exec. V.P. and CFO | 01/30/2013 | 29,552 |
Boissonneault Roger M | CEO & President | 01/30/2013 | 113,363 |
Fenton Andrew | Senior V.P., CIO | 01/22/2013 | 8,383 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/22/2013 | 15,741 |
Gilligan Claire A | Senior V.P., Quality | 01/22/2013 | 12,811 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/22/2013 | 16,497 |
Cross Leland H | Senior V.P., Tech. Operations | 01/22/2013 | 11,326 |
Fuhrmann Rochelle | Senior V.P., Finance | 01/22/2013 | 6,588 |
Halstead Michael | Senior V.P., Corp. Development | 01/22/2013 | 6,588 |
Herendeen Paul | Exec. V.P. and CFO | 01/22/2013 | 58,117 |
Boissonneault Roger M | CEO & President | 01/22/2013 | 187,973 |
Murray Stephen P | Director | 11/28/2012 | 74,069,360 |
Murray Stephen P | Director | 11/20/2012 | 58,299,999 |
Gilligan Claire A | Senior V.P., Quality | 10/01/2012 | 3,577 |
Halstead Michael | Senior V.P., Corp. Development | 10/01/2012 | 1,043 |
BAIN CAPITAL INVESTORS LLC | 10% Owner | 09/11/2012 | 168,864,887 |
CONNAUGHTON JOHN | Director | 09/11/2012 | 168,864,887 |
THL WC (Dutch) B.V. | 10% Owner | 09/11/2012 | 183,400,005 |
ABBRECHT TODD M | Director | 09/11/2012 | 183,400,005 |
Hara Izumi | Senior V.P. | 09/11/2012 | 1,663,608 |
Herendeen Paul | Exec. V.P. and CFO | 09/11/2012 | 4,051,044 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 09/11/2012 | 1,934,071 |
Ellman Herman | Senior V.P., Clinical Devel. | 09/11/2012 | 307,850 |
Murray Stephen P | Director | 09/11/2012 | 183,400,005 |
JPMP MASTER FUND MANAGER L P | 10% Owner | 09/11/2012 | 376,787,778 |
JP MORGAN PARTNERS BHCA LP | 10% Owner | 09/11/2012 | 376,787,778 |
Halstead Michael | Senior V.P., Corp. Development | 07/02/2012 | 6,376 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 04/02/2012 | 11,916 |
Cross Leland H | Senior V.P., Tech. Operations | 03/01/2012 | 9,486 |
Fenton Andrew | Senior V.P., CIO | 03/01/2012 | 6,562 |
Gilligan Claire A | Senior V.P., Quality | 03/01/2012 | 16,540 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 03/01/2012 | 12,069 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 03/01/2012 | 12,069 |
Fuhrmann Rochelle | Senior V.P., Finance | 03/01/2012 | 12,069 |
Halstead Michael | Senior V.P., Corp. Development | 03/01/2012 | 12,324 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 03/01/2012 | 42,243 |
Herendeen Paul | Exec. V.P. and CFO | 03/01/2012 | 31,058 |
Boissonneault Roger M | CEO & President | 03/01/2012 | 90,436 |
Fenton Andrew | Senior V.P., CIO | 02/21/2012 | 6,880 |
Gilligan Claire A | Senior V.P., Quality | 02/21/2012 | 17,327 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 02/21/2012 | 12,651 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 02/21/2012 | 12,651 |
Cross Leland H | Senior V.P., Tech. Operations | 02/21/2012 | 9,925 |
Fuhrmann Rochelle | Senior V.P., Finance | 02/21/2012 | 12,651 |
Ellman Herman | Senior V.P., Clinical Devel. | 02/21/2012 | 11,389 |
Halstead Michael | Senior V.P., Corp. Development | 02/21/2012 | 6,880 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 02/21/2012 | 43,082 |
Herendeen Paul | Exec. V.P. and CFO | 02/21/2012 | 32,518 |
Boissonneault Roger M | CEO & President | 02/21/2012 | 94,677 |
Fenton Andrew | Senior V.P., CIO | 01/30/2012 | 5,775 |
Gilligan Claire A | Senior V.P., Quality | 01/30/2012 | 7,897 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 01/30/2012 | 10,447 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/30/2012 | 9,526 |
Cross Leland H | Senior V.P., Tech. Operations | 01/30/2012 | 8,292 |
Fuhrmann Rochelle | Senior V.P., Finance | 01/30/2012 | 4,623 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/30/2012 | 9,526 |
Halstead Michael | Senior V.P., Corp. Development | 01/30/2012 | 5,265 |
van Zoonen Marinus Johannes | President, Europe/Int'l & Mkt. | 01/30/2012 | 36,441 |
Herendeen Paul | Exec. V.P. and CFO | 01/30/2012 | 35,980 |
Boissonneault Roger M | CEO & President | 01/30/2012 | 136,829 |
Fenton Andrew | Senior V.P., CIO | 01/23/2012 | 10,755 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 01/23/2012 | 20,246 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/23/2012 | 21,216 |
Gilligan Claire A | Senior V.P., Quality | 01/23/2012 | 16,159 |
Fuhrmann Rochelle | Senior V.P., Finance | 01/23/2012 | 8,435 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/23/2012 | 20,246 |
Halstead Michael | Senior V.P., Corp. Development | 01/23/2012 | 8,435 |
Cross Leland H | Senior V.P., Tech. Operations | 01/23/2012 | 15,951 |
Herendeen Paul | Exec. V.P. and CFO | 01/23/2012 | 71,859 |
Boissonneault Roger M | CEO & President | 01/23/2012 | 236,446 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/11/2012 | 19,093 |
Fuhrmann Rochelle | Senior V.P., Finance | 01/11/2012 | 6,847 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/11/2012 | 17,360 |
Halstead Michael | Senior V.P., Corp. Development | 01/11/2012 | 7,531 |
Fenton Andrew | Senior V.P., CIO | 01/11/2012 | 9,297 |
Gilligan Claire A | Senior V.P., Quality | 01/11/2012 | 13,978 |
Cross Leland H | Senior V.P., Tech. Operations | 01/11/2012 | 15,128 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 01/11/2012 | 18,243 |
Fawzi Mahdi B | President, Research & Develop. | 10/21/2011 | 40,623 |
Gilligan Claire A | Senior V.P., Quality | 10/03/2011 | 3,788 |
Halstead Michael | Senior V.P., Corp. Development | 10/03/2011 | 1,094 |
Cross Leland H | Senior V.P., Tech. Operations | 06/10/2011 | 1,773,746 |
Cross Leland H | Senior V.P., Tech. Operations | 06/09/2011 | 2,241,010 |
van Zoonen Marinus Johannes | Pres., Europe/Int'l&Glob. Mkt. | 04/01/2011 | 16,380 |
CONNAUGHTON JOHN | Director | 03/30/2011 | 10,459,713 |
BAIN CAPITAL INVESTORS LLC | 10% Owner | 03/30/2011 | 10,459,713 |
THL WC (Dutch) B.V. | 10% Owner | 03/30/2011 | 10,461,394 |
BAIN CAPITAL INVESTORS LLC | 10% Owner | 03/30/2011 | 10,010,987 |
CONNAUGHTON JOHN | Director | 03/30/2011 | 10,010,987 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 03/30/2011 | 86,327 |
Gilligan Claire A | Senior V.P. Global Quality | 03/30/2011 | 23,971 |
Gilligan Claire A | Senior V.P. Global Quality | 03/30/2011 | 11,904 |
Ellman Herman | Senior V.P., Clinical Devel. | 03/30/2011 | 82,445 |
Herendeen Paul | Exec. V.P. and CFO | 03/30/2011 | 358,190 |
Reichel Carl W | President, Pharmaceuticals | 03/30/2011 | 418,965 |
Bruno Anthony D | Exec. V.P., Corp. Development | 03/30/2011 | 391,716 |
JPMP MASTER FUND MANAGER L P | 10% Owner | 03/30/2011 | 20,919,360 |
JP MORGAN PARTNERS BHCA LP | 10% Owner | 03/30/2011 | 20,919,360 |
Murray Stephen P | Director | 03/30/2011 | 10,459,669 |
CONNAUGHTON JOHN | Director | 03/16/2011 | 155,253,544 |
BAIN CAPITAL INVESTORS LLC | 10% Owner | 03/16/2011 | 155,253,544 |
JPMP MASTER FUND MANAGER L P | 10% Owner | 03/16/2011 | 352,747,866 |
JP MORGAN PARTNERS BHCA LP | 10% Owner | 03/16/2011 | 352,747,866 |
THL WC (Dutch) B.V. | 10% Owner | 03/16/2011 | 182,778,666 |
MURRAY STEPHEN | Director | 03/16/2011 | 176,381,786 |
Hara Izumi | Sr. VP, Gen. Counsel & Sec. | 03/16/2011 | 1,477,096 |
Gilligan Claire A | Senior V.P. Global Quality | 03/16/2011 | 203,996 |
Gilligan Claire A | Senior V.P. Global Quality | 03/16/2011 | 410,060 |
Ellman Herman | Senior V.P., Clinical Devel. | 03/16/2011 | 1,410,531 |
Bruno Anthony D | Exec. V.P., Corp. Development | 03/16/2011 | 9,300,000 |
Herendeen Paul | Exec. V.P. and CFO | 03/16/2011 | 9,300,000 |
Reichel Carl W | President, Pharmaceuticals | 03/16/2011 | 9,300,000 |
Fuhrmann Rochelle | Senior V.P., Global Finance | 01/31/2011 | 6,491 |
Gilligan Claire A | Senior V.P. Global Quality | 01/31/2011 | 11,068 |
van Zoonen Marinus Johannes | Pres., Europe/Int'l&Glob. Mkt. | 01/31/2011 | 51,719 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/31/2011 | 13,356 |
Cross Leland H | Senior V.P., Tech. Operations | 01/31/2011 | 13,356 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/31/2011 | 13,356 |
Herendeen Paul | Exec. V.P. and CFO | 01/31/2011 | 50,248 |
Bruno Anthony D | Exec. V.P., Corp. Development | 01/31/2011 | 50,248 |
Reichel Carl W | President, Pharmaceuticals | 01/31/2011 | 50,248 |
Boissonneault Roger M | CEO & President | 01/31/2011 | 192,120 |
Cross Leland H | Senior V.P., Tech. Operations | 01/21/2011 | 24,898 |
Fuhrmann Rochelle | Senior V.P., Global Finance | 01/21/2011 | 11,457 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/21/2011 | 27,496 |
Gilligan Claire A | Senior V.P. Global Quality | 01/21/2011 | 21,945 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/21/2011 | 28,795 |
Reichel Carl W | President, Pharmaceuticals | 01/21/2011 | 96,757 |
Herendeen Paul | Exec. V.P. and CFO | 01/21/2011 | 96,757 |
Bruno Anthony D | Exec. V.P., Corp. Development | 01/21/2011 | 96,780 |
Boissonneault Roger M | CEO & President | 01/21/2011 | 320,789 |
Cross Leland H | Senior V.P., Tech. Operations | 01/11/2011 | 24,566 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 01/11/2011 | 27,022 |
Ellman Herman | Senior V.P., Clinical Devel. | 01/11/2011 | 24,566 |
Gilligan Claire A | Senior V.P. Global Quality | 01/11/2011 | 19,772 |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | 09/27/2010 | 14,765,315 |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | 09/24/2010 | 37,578,914 |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | 09/23/2010 | 8,985,466 |
AlpInvest Partners CS Investments 2003 C.V. | 10% Owner | 09/22/2010 | 11,030,021 |
Fawzi Mahdi B | President, Research & Develop. | 10/21/2010 | 59,701 |
CREDIT SUISSE AG/ | 10% Owner | 09/30/2010 | 322,199,993 |
CREDIT SUISSE AG/ | 10% Owner | 09/29/2010 | 7,263,190 |
CREDIT SUISSE AG/ | 10% Owner | 09/28/2010 | 12,955,440 |
Gilligan Claire A | Senior V.P. Global Quality | 09/22/2010 | 22,034 |
Cross Leland H | Senior V.P., Tech. Operations | 09/22/2010 | 26,990 |
Howard Alvin D | Sr. V.P., Regulatory Affairs | 09/22/2010 | 32,775 |
Ellman Herman | Senior V.P., Clinical Devel. | 09/22/2010 | 26,990 |
CREDIT SUISSE AG/ | 10% Owner | 09/14/2010 | 2,745,383 |
CREDIT SUISSE AG/ | 10% Owner | 09/13/2010 | 853,673 |
CREDIT SUISSE AG/ | 10% Owner | 09/10/2010 | 2,419,103 |
BLOEM JAMES H | Director | 08/13/2010 | 311,308 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...